Cryptolepis Lyme disease support is a promising option for those suffering from the effects of the disease.
A 1992 report by the Institute of Medicine on emerging microbial threats highlighted the emergence of Lyme disease and other new tick-borne diseases. Unfortunately, the world’s efforts to contain these new bacterial infections have not been successful due to human demographics, microbial adaptation, and economic developments.
The World Health Organization (WHO) estimates that vector-borne infections account for 17% of new microbial infections. Most recently, tick-transmitted bacterial infections have received much attention due to their increased incidence.
The Centers for Disease Control estimates that over 476,000 Americans are infected with Lyme disease every year. In addition, many people suffer the lingering effects of Lyme disease for long periods of time. (Michael Van der Linden, owner of Linden Botanicals, suffered from Lyme disease for almost 4 years.) Today, it’s more important than ever to embrace preventive measures for the disease instead of focusing on treatment alone.
In this post, I’ll review some details of tick-transmitted Lyme disease, as well as discuss Cryptolepis Lyme disease support.
Lyme Disease Symptoms
According to Bay Area Lyme Foundation, Lyme disease symptoms vary greatly depending on a range of factors such as infections strain, duration of infection, and heterogeneity of the immune system.
Some common early symptoms of Lyme disease include a rash that may occur between 3 and 30 days from the day of tick infection. Sometimes you may see a reddening at the affected site. Over time, the rash expands up to 12 inches and may be itchy or occasionally painful. Some people may develop the rash on many parts of the body. Some people also experience fever, body aches, swollen lymph, headache, fatigue, and chills.
If left untreated, the symptoms may worsen to:
- Erythema Migrans: This condition occurs when the rash extends to other parts of the body.
- Joint Pain: Some people experience pain in the knees and joints.
- Neurological Problems: Neuro Lyme can at times result in limb weakness and temporary paralysis.
Cryptolepis Lyme disease support may not only help to address these symptoms but also has the potential to help prevent these symptoms from occurring in the first place.
Cryptolepis Lyme Disease Support
Lyme disease is caused by the bacteria Borrelia burgdorferi, which is usually transmitted to the body through a tick bite. Treating the disease requires remedies that offer antibacterial properties against the causative bacteria and anti-inflammatory properties against symptoms that occur to the host.
Cryptolepis Lyme support is based on the herb’s anti-inflammatory and antibacterial properties. Preliminary studies document that the herb is effective in supporting treatment of Lyme disease without side effects as compared with chemically engineered drugs. In addition, Cryptolepis sanguinolenta use is common in China, India, and, increasingly, North America and other parts of the world.
In particular, Cryptolepis herbal extract has shown potential antibacterial activity against tick-borne infections such as Lyme Borrelia burgdorferi and Bartonella henselae. The presence of bioactive compounds such as cryptolepine, the main alkaloid in the herb, has shown effective activity against both Gram-positive and Gram-negative bacteria.
Cryptolepis may have an important supportive role in the need to develop novel treatment strategies against persister microcolonies of Borrelia burgdorferi. A 2020 study in Frontiers in Medicine found Cryptolepis to be highly active in vitro against both growing Borrelia burgdorferi and non-growing stationary phase Borrelia burgdorferi.
Cryptolepis as an Anti-Inflammatory
Biscryptolepine has proved to inhibit Cox-2, which causes pain and inflammation. A study conducted in rats showed the herb’s ability to reduce inflammation within the first day.
Cryptolepis as an Antibacterial
Cryptolepis sanguinolenta contains a range of bioactive compounds such as:
- Phenolic acids
Neocryptolepine is the main bioactive compound that has shown putative antibacterial properties against a range of Gram-positive bacteria. It has also shown anti-fungal properties.
Learn More About Cryptolepis Today
Learn more about how Cryptolepis Lyme disease support may help address Lyme disease symptoms or even help to prevent the more serious effects of disease. We encourage you to start with the Cryptolepis FAQ and our Lyme disease resources.